WANG YULUN 4
4 · Teladoc Health, Inc. · Filed Dec 7, 2020
Insider Transaction Report
Form 4
WANG YULUN
Head of Research & Development
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2020-12-04−1,069→ 0 totalExercise: $16.92Exp: 2026-02-04→ Common Stock (1,069 underlying) - Sale
Common Stock
2020-12-04$202.00/sh−5,000$1,010,000→ 0 total - Sale
Common Stock
2020-12-04$198.00/sh−1,069$211,662→ 0 total - Exercise/Conversion
Common Stock
2020-12-04$16.92/sh+1,069$18,087→ 1,069 total - Exercise/Conversion
Common Stock
2020-12-04$16.92/sh+5,000$84,600→ 5,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-12-04−5,000→ 59,865 totalExercise: $16.92Exp: 2026-07-13→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The option vested in full on July 1, 2020.